US Stock MarketDetailed Quotes

STRO Sutro Biopharma

Watchlist
  • 3.790
  • +0.480+14.50%
Close Oct 11 16:00 ET
  • 3.800
  • +0.010+0.26%
Post 19:45 ET
310.64MMarket Cap-2129P/E (TTM)

Sutro Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
146.89%25.71M
2.64%13.01M
126.84%153.73M
1,217.44%113.72M
-32.70%16.92M
-62.94%10.41M
114.92%12.67M
9.52%67.77M
-18.98%8.63M
195.26%25.15M
Operating revenue
146.89%25.71M
2.64%13.01M
126.84%153.73M
1,217.44%113.72M
-32.70%16.92M
-62.94%10.41M
114.92%12.67M
9.52%67.77M
-18.98%8.63M
195.26%25.15M
Cost of revenue
Gross profit
Operating expense
31.45%74.39M
26.75%69.6M
23.53%243.01M
21.98%70.57M
31.45%60.94M
19.20%56.59M
21.95%54.91M
22.64%196.72M
26.62%57.85M
7.33%46.36M
Selling and administrative expenses
-17.52%12.37M
-17.99%12.72M
5.11%62.58M
14.17%16.8M
4.28%15.27M
-0.95%15M
3.15%15.51M
6.32%59.54M
-6.62%14.72M
-11.73%14.64M
-General and administrative expense
-17.52%12.37M
-17.99%12.72M
5.11%62.58M
14.17%16.8M
4.28%15.27M
-0.95%15M
3.15%15.51M
6.32%59.54M
-6.62%14.72M
-11.73%14.64M
Research and development costs
49.12%62.02M
44.36%56.88M
31.53%180.43M
24.64%53.77M
44.00%45.67M
28.64%41.59M
31.37%39.4M
31.39%137.17M
44.13%43.14M
19.22%31.71M
Operating profit
-5.43%-48.69M
-33.98%-56.59M
30.76%-89.28M
187.67%43.15M
-107.52%-44.01M
-138.29%-46.18M
-7.93%-42.24M
-30.87%-128.94M
-40.49%-49.22M
38.83%-21.21M
Net non-operating interest income expense
-702.52%-4.13M
-1,144.37%-5.3M
-8,577.06%-9.24M
-247.96%-4.17M
-132.53%-4.13M
-29.72%-515K
21.26%-426K
104.26%109K
646.71%2.82M
-149.51%-1.77M
Non-operating interest income
72.80%4.91M
60.00%4.1M
319.97%14.51M
114.19%4.56M
348.72%4.55M
1,342.64%2.84M
2,106.90%2.56M
498.79%3.46M
2,116.67%2.13M
830.28%1.01M
Non-operating interest expense
169.41%9.04M
214.70%9.4M
609.80%23.75M
1,360.03%8.73M
211.15%8.68M
465.15%3.36M
354.49%2.99M
6.66%3.35M
-213.24%-693K
240.00%2.79M
Other net income (expense)
-42.22%4.81M
152.62%3.68M
-18.24%9.92M
-33.14%7.89M
-80.15%694K
322.72%8.32M
-1,341.92%-6.99M
372.34%12.13M
558.88%11.81M
-22.02%3.5M
Gain on sale of security
-42.22%4.81M
152.62%3.68M
-18.24%9.92M
-33.14%7.89M
-80.15%694K
322.72%8.32M
-1,341.92%-6.99M
372.34%12.13M
558.88%11.81M
-22.02%3.5M
Income before tax
-25.11%-48.01M
-17.23%-58.21M
24.08%-88.6M
235.49%46.87M
-143.46%-47.45M
-63.21%-38.37M
-26.96%-49.66M
-10.58%-116.7M
9.26%-34.59M
36.94%-19.49M
Income tax
-94.70%8K
0
627.68%18.19M
15.81M
1.84M
-93.96%151K
395K
2.5M
0
0
Net income
-24.64%-48.02M
-16.31%-58.21M
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
-12.95%-119.2M
9.26%-34.59M
36.94%-19.49M
Net income continuous Operations
-24.64%-48.02M
-16.31%-58.21M
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
-12.95%-119.2M
9.26%-34.59M
36.94%-19.49M
Minority interest income
Net income attributable to the parent company
-24.64%-48.02M
-16.31%-58.21M
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
-12.95%-119.2M
9.26%-34.59M
36.94%-19.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-24.64%-48.02M
-16.31%-58.21M
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
-12.95%-119.2M
9.26%-34.59M
36.94%-19.49M
Basic earnings per share
7.81%-0.59
-11.76%-0.95
24.26%-1.78
185.25%0.52
-118.92%-0.81
-16.36%-0.64
-1.19%-0.85
-2.62%-2.35
26.51%-0.61
44.78%-0.37
Diluted earnings per share
7.81%-0.59
-11.76%-0.95
24.26%-1.78
185.25%0.52
-118.92%-0.81
-16.36%-0.64
-1.19%-0.85
-2.62%-2.35
26.51%-0.61
44.78%-0.37
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 146.89%25.71M2.64%13.01M126.84%153.73M1,217.44%113.72M-32.70%16.92M-62.94%10.41M114.92%12.67M9.52%67.77M-18.98%8.63M195.26%25.15M
Operating revenue 146.89%25.71M2.64%13.01M126.84%153.73M1,217.44%113.72M-32.70%16.92M-62.94%10.41M114.92%12.67M9.52%67.77M-18.98%8.63M195.26%25.15M
Cost of revenue
Gross profit
Operating expense 31.45%74.39M26.75%69.6M23.53%243.01M21.98%70.57M31.45%60.94M19.20%56.59M21.95%54.91M22.64%196.72M26.62%57.85M7.33%46.36M
Selling and administrative expenses -17.52%12.37M-17.99%12.72M5.11%62.58M14.17%16.8M4.28%15.27M-0.95%15M3.15%15.51M6.32%59.54M-6.62%14.72M-11.73%14.64M
-General and administrative expense -17.52%12.37M-17.99%12.72M5.11%62.58M14.17%16.8M4.28%15.27M-0.95%15M3.15%15.51M6.32%59.54M-6.62%14.72M-11.73%14.64M
Research and development costs 49.12%62.02M44.36%56.88M31.53%180.43M24.64%53.77M44.00%45.67M28.64%41.59M31.37%39.4M31.39%137.17M44.13%43.14M19.22%31.71M
Operating profit -5.43%-48.69M-33.98%-56.59M30.76%-89.28M187.67%43.15M-107.52%-44.01M-138.29%-46.18M-7.93%-42.24M-30.87%-128.94M-40.49%-49.22M38.83%-21.21M
Net non-operating interest income expense -702.52%-4.13M-1,144.37%-5.3M-8,577.06%-9.24M-247.96%-4.17M-132.53%-4.13M-29.72%-515K21.26%-426K104.26%109K646.71%2.82M-149.51%-1.77M
Non-operating interest income 72.80%4.91M60.00%4.1M319.97%14.51M114.19%4.56M348.72%4.55M1,342.64%2.84M2,106.90%2.56M498.79%3.46M2,116.67%2.13M830.28%1.01M
Non-operating interest expense 169.41%9.04M214.70%9.4M609.80%23.75M1,360.03%8.73M211.15%8.68M465.15%3.36M354.49%2.99M6.66%3.35M-213.24%-693K240.00%2.79M
Other net income (expense) -42.22%4.81M152.62%3.68M-18.24%9.92M-33.14%7.89M-80.15%694K322.72%8.32M-1,341.92%-6.99M372.34%12.13M558.88%11.81M-22.02%3.5M
Gain on sale of security -42.22%4.81M152.62%3.68M-18.24%9.92M-33.14%7.89M-80.15%694K322.72%8.32M-1,341.92%-6.99M372.34%12.13M558.88%11.81M-22.02%3.5M
Income before tax -25.11%-48.01M-17.23%-58.21M24.08%-88.6M235.49%46.87M-143.46%-47.45M-63.21%-38.37M-26.96%-49.66M-10.58%-116.7M9.26%-34.59M36.94%-19.49M
Income tax -94.70%8K0627.68%18.19M15.81M1.84M-93.96%151K395K2.5M00
Net income -24.64%-48.02M-16.31%-58.21M10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M-12.95%-119.2M9.26%-34.59M36.94%-19.49M
Net income continuous Operations -24.64%-48.02M-16.31%-58.21M10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M-12.95%-119.2M9.26%-34.59M36.94%-19.49M
Minority interest income
Net income attributable to the parent company -24.64%-48.02M-16.31%-58.21M10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M-12.95%-119.2M9.26%-34.59M36.94%-19.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -24.64%-48.02M-16.31%-58.21M10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M-12.95%-119.2M9.26%-34.59M36.94%-19.49M
Basic earnings per share 7.81%-0.59-11.76%-0.9524.26%-1.78185.25%0.52-118.92%-0.81-16.36%-0.64-1.19%-0.85-2.62%-2.3526.51%-0.6144.78%-0.37
Diluted earnings per share 7.81%-0.59-11.76%-0.9524.26%-1.78185.25%0.52-118.92%-0.81-16.36%-0.64-1.19%-0.85-2.62%-2.3526.51%-0.6144.78%-0.37
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.67%